Palatin Technologies' management will discuss the fourth quarter and year end financial results for the fiscal year ended June 30, 2007 and provide an update on corporate developments during a conference call and webcast on September 18, 2007 at 10:00 a.m. ET.
Conference Call and Webcast Access Information
-- Q4-Fiscal Year 2007 Conference Call - Live 9/18/2007 at 10:00 a.m. ET
Domestic Dial-In Number 1-866-454-4203
International Dial-In Number 1-913-312-6693
-- Q4-Fiscal Year 2007 Conference Call - Replay 9/18-9/25/2007
Domestic Dial-In Number 1-888-203-1112
International Dial-In Number 1-719-457-0820
Enter Pass Code I.D. # 4280242
-- Webcast Live and Replay Access http://www.palatin.com
The webcast and replay can be accessed by logging on to the investors
section of Palatin Technologies' website at http://www.palatin.com.
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company focused on
discovering and developing targeted, receptor-specific small molecule and
peptide therapeutics. The Company's internal research and development
capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling
product development. Palatin's strategy is to develop products and then
form marketing collaborations with industry leaders in order to maximize
their commercial potential. The Company currently has collaborations with
AstraZeneca and the Mallinckrodt division of Covidien. For additional
information regarding Palatin, please visit Palatin Technologies' websit
|SOURCE Palatin Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved